Status:
COMPLETED
Identification of Modifying Factors in Hereditary Spastic Paraplegia
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hereditary Spastic Paraplegia
Eligibility:
All Genders
18+ years
Brief Summary
A first questionnaire - MODIFSPA conducted in 2014 - identified several environmental factors influencing spasticity in HSP: cold, fatigue, and especially physical activity. In order to improve the ca...
Detailed Description
The only common symptom of hereditary spastic paraplegia (HSP) is the presence of spasticity in the lower limbs, associated with a great clinical and genetic heterogeneity. A first MODIFSPA study car...
Eligibility Criteria
Inclusion
- French-speaking adult patients aware of their PSH diagnosis coming to the genetic consultation at the Pitié-Salpêtrière Hospital or informed via an association / website of the BRAINTEAM study network
- Affiliated with social security
Exclusion
- NA
Key Trial Info
Start Date :
October 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 3 2023
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT05373082
Start Date
October 4 2022
End Date
October 3 2023
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut du Cerveau, ICM
Paris, France, 75013